Last reviewed · How we verify

NCT05165368

Effect of Gluten-Free Dietary Education and Intraneural Facilitation® Therapy on Quality of Life in People With Diabetic Neuropathy

Completed NA Last updated 14 August 2025
What this trial tests

NA trial testing Intraneural Facilitation® Therapy (INF® Therapy) in Diabetic Neuropathy, Distal Symmetric Polyneuropathy (Manifestation) in 46 participants. Completed in 20 May 2025.

Timeline
1 August 2023
Primary endpoint
20 May 2025
20 May 2025

Quick facts

Lead sponsorLoma Linda University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment46
Start date1 August 2023
Primary completion20 May 2025
Estimated completion20 May 2025
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Loma Linda University

Who can join

Adults 50 to 75, any sex, with Diabetic Neuropathy, Distal Symmetric Polyneuropathy (Manifestation). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this research is to compare the effectiveness of providing dietary education to complement Intraneural Facilitation® Therapy (INF® Therapy) (a physical therapy technique being evaluated that may help improve circulation) versus INF® Therapy only in adults with a type of neuropathy called distal symmetric polyneuropathy (DSPN).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Diabetic Neuropathy, Distal Symmetric Polyneuropathy (Manifestation)

Currently open trials in the same condition.

Other Loma Linda University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05165368.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing